This is my concern @sunny coast In the US, drug development progress of this magnitude would cause a massive surge in the SP. Here in Aus - reactions are much more muted. I'd like to see PAR announce a roadshow to US instos as part of this.
Would have to be done over Zoom given the state of the world, but increasing US exposure has to be part of the strategy as they proceed to Phase 3.
Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-41
-
- There are more pages in this discussion • 233 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.5¢ | $537 | 2.287K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 94083 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 73569 | 4 |
View Market Depth
| Last trade - 10.06am 19/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |